构建国家基本药物目录适时调整管理机制的必要性与可行性分析[1]

Study on necessity and feasibility of timely adjustment management of essential medicine list in China

关键词:  国家基本药物目录  适时调整  必要性  可行性

Key words:  Essential drug list  Timely adjustment  Necessity  Feasibility

摘要:

目的 研究我国国家基本药物目录适时调整的必要性和可行性，为完善国家基本药物目录动态调整管理机制提出政策建议。方法 运用文献研究从我国基本国情和药品供应保障水平、药物研发新形势、指南调整周期新变化三个维度分析必要性；基于国内法律法规基础和典型国家经验分析可行性。结果 为促使国家基本药物目录更符合我国基本国情和药品供应保障水平、更适应药物研发新形势和指南调整周期新变化，我国有必要建立国家基本药物目录适时调整管理机制；同时我国具备实施适时调整的法律法规依据和典型国家的经验参考依据，具有可行性。结论 进一步完善我国国家基本药物目录动态调整管理机制，明确建立三年一次的常规调整与一年一次的适时调整相结合的动态调整机制，同时并制定相关的配套政策，进一步提高我国国家基本药物目录先进性和合理性，使其更加贴近临床需求，更好发挥在保障药品供应、促进临床合理用药、改善药品可及性等方面的重要作用。

Abstract:

Objective To study the necessity and feasibility of timely adjustment of essential drug list (hereinafter referred to as essential drug list) in China, and to put forward policy suggestions for improving the dynamic adjustment management mechanism of essential drug list. Methods The necessity was analyzed from three dimensions: the basic national conditions of China, the level of drug supply security, the new situation of drug research and development, and the new change of guideline adjustment cycle. The feasibility is analyzed based on domestic laws and regulations and typical national experience. Results In order to make the basic drug list more in line with China"s basic national conditions and the level of drug supply, adapt to the new situation of drug research and development and the new change of guideline adjustment cycle, it is necessary to establish a timely adjustment management mechanism of the basic drug list. At the same time, China has the legal and regulatory basis for implementing timely adjustment and the experience reference basis of typical countries, which is feasible. CONCLUSIONS To further improve the dynamic adjustment management mechanism of China"s basic drug catalog, clearly establish a dynamic adjustment mechanism combining triennium routine adjustment and yearly timely adjustment, and formulate relevant supporting policies to further improve the advanced nature and rationality of China"s basic drug catalog, so as to make it closer to clinical needs. It plays an important role in ensuring drug supply, promoting clinical rational drug use, and improving drug accessibility.